Regarding melanoma pathology, when comparing public data from patients between the diagnosis and metastatic stages [16], significant frequencies of amplification (14.5% and 10.0% respectively) were observed for the SELENBP1 and SEPTIN9 genes at the metastatic stage (Table 1). The gene discussed is SELENBP1; the disease is melanoma.